Seasonal manifestations of sickle cell disease activity

Chunliang Xu; Paul S. Frenette

doi:10.1038/s41591-019-0409-3

Seasonal manifestations of sickle cell disease activity

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	536-537
Number of pages	2
Journal	Nature Medicine
Volume	25
Issue number	4
DOIs	https://doi.org/10.1038/s41591-019-0409-3
State	Published - Apr 1 2019

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1038/s41591-019-0409-3

Cite this

@article{f864ee4e215d45f4ad2174adb523bd2f,

title = "Seasonal manifestations of sickle cell disease activity",

author = "Chunliang Xu and Frenette, {Paul S.}",

note = "Funding Information: This work was supported by R01 grants from the National Institutes of Health (NIH) (HL069438, DK056638, DK116312, DK112976) to P.S.F. Funding Information: P.S.F. has served as consultant for Pfizer, received research funding from Ironwood Pharmaceuticals and owns stock options of Cygnal Therapeutics.",

year = "2019",

month = apr,

day = "1",

doi = "10.1038/s41591-019-0409-3",

language = "English (US)",

volume = "25",

pages = "536--537",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Seasonal manifestations of sickle cell disease activity

AU - Xu, Chunliang

AU - Frenette, Paul S.

N1 - Funding Information: This work was supported by R01 grants from the National Institutes of Health (NIH) (HL069438, DK056638, DK116312, DK112976) to P.S.F. Funding Information: P.S.F. has served as consultant for Pfizer, received research funding from Ironwood Pharmaceuticals and owns stock options of Cygnal Therapeutics.

PY - 2019/4/1

Y1 - 2019/4/1

UR - http://www.scopus.com/inward/record.url?scp=85063990492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063990492&partnerID=8YFLogxK

U2 - 10.1038/s41591-019-0409-3

DO - 10.1038/s41591-019-0409-3

M3 - Letter

C2 - 30948854

AN - SCOPUS:85063990492

VL - 25

SP - 536

EP - 537

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 4

ER -